Clinical trial
ADVANCE - Action in Diabetes and Vascular Disease: Preterax and Diamicron - MR Controlled Evaluation
NCT00145925 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ADVANCE - Action in Diabetes and Vascular Disease: Preterax and Diamicron - MR Controlled Evaluation
- Lead sponsor
- The George Institute
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2001
- Completion date
- March 31, 2008
- Enrollment
- 11,140 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.